STERIS Return on Tangible Equity 2010-2022 | STE

Current and historical return on tangible equity values for STERIS (STE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
STERIS Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2022-09-30 $-0.01B $-0.97B 0.69%
2022-06-30 $0.38B $-1.10B -29.04%
2022-03-31 $0.24B $-1.19B -16.69%
2021-12-31 $0.28B $-1.37B -23.78%
2021-09-30 $0.25B $-1.54B -29.27%
2021-06-30 $0.29B $-1.75B -96.87%
2021-03-31 $0.40B $-0.03B 140.26%
2020-12-31 $0.43B $-0.09B 104.26%
2020-09-30 $0.42B $0.69B 78.70%
2020-06-30 $0.41B $0.57B 91.63%
2020-03-31 $0.41B $0.50B 106.53%
2019-12-31 $0.39B $0.40B 121.58%
2019-09-30 $0.34B $0.34B 126.55%
2019-06-30 $0.32B $0.30B 152.15%
2019-03-31 $0.30B $0.26B 199.34%
2018-12-31 $0.27B $0.17B 264.37%
2018-09-30 $0.32B $0.12B 495.69%
2018-06-30 $0.30B $0.07B 1361.80%
2018-03-31 $0.29B $0.06B -1337.93%
2017-12-31 $0.24B $0.02B -335.17%
2017-09-30 $0.14B $-0.05B -119.92%
2017-06-30 $0.12B $-0.11B -79.47%
2017-03-31 $0.11B $-0.15B -62.29%
2016-12-31 $0.14B $-0.17B -70.94%
2016-09-30 $0.17B $-0.17B -70.49%
2016-06-30 $0.14B $-0.21B -71.71%
2016-03-31 $0.11B $-0.24B -121.98%
2015-12-31 $0.09B $-0.32B 417.78%
2015-09-30 $0.11B $0.02B 71.79%
2015-06-30 $0.13B $0.18B 66.50%
2015-03-31 $0.14B $0.21B 67.25%
2014-12-31 $0.13B $0.22B 60.18%
2014-09-30 $0.12B $0.20B 50.72%
2014-06-30 $0.12B $0.18B 45.94%
2014-03-31 $0.13B $0.29B 44.56%
2013-12-31 $0.13B $0.31B 47.31%
2013-09-30 $0.15B $0.29B 59.39%
2013-06-30 $0.16B $0.27B 63.01%
2013-03-31 $0.16B $0.24B 50.80%
2012-12-31 $0.16B $0.21B 43.37%
2012-09-30 $0.15B $0.30B 34.20%
2012-06-30 $0.14B $0.50B 29.42%
2012-03-31 $0.14B $0.49B 29.69%
2011-12-31 $0.13B $0.45B 28.84%
2011-09-30 $0.12B $0.44B 26.42%
2011-06-30 $0.13B $0.47B 28.05%
2011-03-31 $0.05B $0.47B 12.11%
2010-12-31 $0.04B $0.43B 10.14%
2010-09-30 $0.06B $0.42B 14.72%
2010-06-30 $0.06B $0.39B 13.25%
2010-03-31 $0.13B $0.45B 28.52%
2009-12-31 $0.13B $0.42B 28.65%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $19.157B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00